Compare Enveric Biosciences Inc (ENVB) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Match Group Inc — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Match Group Inc trades at $40.61 (market cap $9.36B). The key difference: Match Group Inc is far larger — about 1759.4× Enveric Biosciences Inc's market cap, and Match Group Inc pays a 1.99% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | MTCH | |
|---|---|---|
Market Cap | $5.32M | $9.36B |
Sector | Health | Media |
52-Week High | $17.40 | $40.11 |
52-Week Low | $1.28 | $28.90 |
Enterprise Value | $408.82K | $12.31B |
Dividend Yield | — | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Match Group (MTCH) trades at $38.34, down 0.52% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 73.8% gross margin and 18.83% net income margin, though Q1 2026 earnings missed expectations. Recent news highlights Tinder's turnaround efforts and Hinge's growth, with upcoming Q2 2026 results on August 4, 2026.
The stock presents a moderate upside to the $41.63 consensus price target, supported by 53% analyst buy ratings. Key risks include Tinder's user decline and high debt levels, while positive cash flow trends and valuation discounts offer potential for patient investors amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
